155 related articles for article (PubMed ID: 7192154)
21. Influence of subclass-specific anti-idiotypic antibodies on the kinetics of the immune response to BCG.
Daus H; Hammer HJ; Rajki K; Mauch H
Immunology; 1984 Aug; 52(4):697-702. PubMed ID: 6611300
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
[TBL] [Abstract][Full Text] [Related]
23. [A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia].
López Nevot MA; Ruiz-Cabello F; Huelin C; Cabrera A; Garrido F
Sangre (Barc); 1986; 31(6):751-8. PubMed ID: 3551142
[No Abstract] [Full Text] [Related]
24. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
Kon S
Gan To Kagaku Ryoho; 1988 May; 15(5):1685-92. PubMed ID: 3259417
[TBL] [Abstract][Full Text] [Related]
25. Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes.
Hough DW; Eady RP; Hamblin TJ; Stevenson FK; Stevenson GT
J Exp Med; 1976 Oct; 144(4):960-9. PubMed ID: 62018
[TBL] [Abstract][Full Text] [Related]
26. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
Tamura GS; McGrath MS; Weissman IL
J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
[TBL] [Abstract][Full Text] [Related]
27. Loss of surface-bound antibody accompanying the anti-complementary modulation of leukemic B cell immunoglobulin: contrasting effects of antibodies directed against idiotypic and constant regions.
Gordon J; Anderson VA; Stevenson GT
J Immunol; 1982 Jun; 128(6):2863-9. PubMed ID: 6804570
[TBL] [Abstract][Full Text] [Related]
28. Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes.
Stevenson FK; Hamblin TJ; Stevenson GT; Tutt AL
J Exp Med; 1980 Dec; 152(6):1484-96. PubMed ID: 6969771
[TBL] [Abstract][Full Text] [Related]
29. [Substitution with immunoglobulins in leukemia].
Schmitz N; Gassmann W; Löffler H
Beitr Infusionther Klin Ernahr; 1982; 9():25-33. PubMed ID: 6756384
[No Abstract] [Full Text] [Related]
30. Activation of a functional idiotype network response by monoclonal antibody specific for a virus (M-MuLV)-induced tumor antigen.
Powell TJ; Spann R; Vakil M; Kearney JF; Lamon EW
J Immunol; 1988 May; 140(9):3266-72. PubMed ID: 3258895
[TBL] [Abstract][Full Text] [Related]
31. Antigen-induced murine B-cell lymphomas. III. Passive anti-idiotype serum therapy and its combined effect with chemotherapy.
Lanier LL; Babcock GF; Lynes MA; Haughton G
J Natl Cancer Inst; 1979 Dec; 63(6):1417-22. PubMed ID: 316036
[No Abstract] [Full Text] [Related]
32. Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.
Austin EB; Robins RA; Durrant LG; Price MR; Baldwin RW
Immunology; 1989 Aug; 67(4):525-30. PubMed ID: 2788611
[TBL] [Abstract][Full Text] [Related]
33. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
Fernandez LA; MacSween JM; Langley GR
Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype.
Raffeld M; Neckers L; Longo DL; Cossman J
N Engl J Med; 1985 Jun; 312(26):1653-8. PubMed ID: 3923351
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody therapy of lymphoid malignancy.
Lowder JN; Meeker TC; Levy R
Cancer Surv; 1985; 4(2):359-75. PubMed ID: 3842318
[TBL] [Abstract][Full Text] [Related]
36. Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapy.
Stevenson FK; Glennie MJ; Johnston DM; Tutt AL; Stevenson GT
Br J Cancer; 1984 Sep; 50(3):407-13. PubMed ID: 6380556
[TBL] [Abstract][Full Text] [Related]
37. Helper T lymphocytes from xid and normal mice support anti-phosphocholine antibody responses with equivalent T15, 511, and 603 idiotypic composition.
Feeney AJ; Mosier DE
J Immunol; 1984 Dec; 133(6):2868-73. PubMed ID: 6238089
[TBL] [Abstract][Full Text] [Related]
38. Regional dichotomy of idiotypic expression on senescent B lymphocytes in systemic and mucosal immune systems: selective changes in NPb and T15 idiotypes with aging.
Haq JA; Khan RH; Szewczuk MR
Reg Immunol; 1992; 4(6):371-80. PubMed ID: 1297407
[TBL] [Abstract][Full Text] [Related]
39. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
40. Selective cytotoxicity against tumor cells by cisplatin complexed to antitumor antibodies via carboxymethyl dextran.
Schechter B; Pauzner R; Arnon R; Haimovich J; Wilchek M
Cancer Immunol Immunother; 1987; 25(3):225-30. PubMed ID: 2445485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]